Drugs / BST08
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06643910 | Oct 2024 → Aug 2026 overdue | non-small cell lung carcinoma | BioSyngen Pte Ltd | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BST08 | “9x10\^10 BST08 cells, Intravenous infusion，3 subject is planned to be enrolled” NCT06643910 ↗ |
| Modality | Cell therapy | “9x10\^10 BST08 cells” NCT06643910 ↗ |
| Route | Intravenous | “Intravenous infusion” NCT06643910 ↗ |